EPISODE · Apr 3, 2024 · 10 MIN
741 - Xolair: The First Drug For Severe Food Allergies
from Public Health On Call · host Johns Hopkins Bloomberg School of Public Health
Xolair is the first FDA-approved therapy to prevent severe and potentially life-threatening reactions in adults and children who are allergic to dairy, eggs, wheat, nuts and other foods. Dr. Robert Wood, the director of pediatric allergy and immunology at Johns Hopkins, talks with Lindsay Smith Rogers about this drug that has the potential to make life a little easier for patients and parents of children with severe allergies.
Embed this episode
Ready to play
741 - Xolair: The First Drug For Severe Food Allergies
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.